4
Changes in Ownership
Emmaus Life Sciences, Inc. Filed Acc 0001209191-21-037935
Chairman and CEO bought 2,065 shares at an average $1.62 ($3,339)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Niihara Yutaka Chairman and CEO | 2021-06-01 | Purchase | +1,600 | $1.61 | $2,576 | 10,755,950 | D |
| Niihara Yutaka Chairman and CEO | 2021-06-02 | Purchase | +465 | $1.64 | $763 | 10,756,415 | D |
| Open-market purchases · 2,065 sh · avg $1.62 · $3,339 | |||||||
Loading xslF345X03/doc4.xml…